trending Market Intelligence /marketintelligence/en/news-insights/trending/v82Dv0KlNu-IuMeKxY7nLA2 content esgSubNav
In This List

Aevi Genomic Medicine completes $28M private placement

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Aevi Genomic Medicine completes $28M private placement

Aevi Genomic Medicine Inc. completed its private placement of common shares and warrants for proceeds of $28 million, before expenses.

The Children's Hospital of Philadelphia Foundation was the lead investor.

Aevi Genomic plans to use net proceeds for the development of its two lead clinical programs and other product candidates, to support its collaboration with Children's Hospital of Philadelphia, and for general corporate purposes.

Jefferies LLC served as financial adviser to Aevi Genomic for the transaction and Evercore LLC served as financial adviser to the Children's Hospital of Philadelphia Foundation.